3 Followers on Owler
Design Therapeutics is a biotechnology company that develops and commercializes therapies for the treatment of degenerative diseases...
Read moreDesign Therapeutics is a biotechnology company that develops and commercializes therapies for the treatment of degenerative diseases...
Read more
2017
PublicIndependent CompanyNASDAQDSGN
News
Mar 18, 2023
Owler
Design Therapeutics, Inc.: Design Therapeutics's employee count changed from 56 in Sep 2022 to 58 in Dec 2022
Mar 14, 2023
MarketScreener
Design Therapeutics: Design Therapeutics Highlights Pipeline Progress and Reports Fourth Quarter and Full Year 2022 Financial Results
Mar 14, 2023
Seeking Alpha
Design Therapeutics: Design Therapeutics GAAP EPS of -$0.31 beats by $0.03
Feb 08, 2023
MarketScreener
Design Therapeutics: Design Therapeutics to Participate in the SVB Securities Virtual Global Biopharma Conference
Jan 07, 2023
NewsFile
Press Release: Design Therapeutics : SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Design Therapeutics, Inc. - DSGN
Dec 17, 2022
NewsFile
Press Release: Design Therapeutics : SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Design Therapeutics, Inc. - DSGN
Dec 08, 2022
GlobalNewswire
Press Release: Design Therapeutics : SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Design Therapeutics, Inc. - DSGN
Dec 07, 2022
MarketScreener
Design Therapeutics: Design Therapeutics Reports Positive Data from Single-Ascending Dose Trial of DT-216 for the Treatment of Friedreich Ataxia and Portfolio Progress
Nov 03, 2022
MarketScreener
Design Therapeutics: Design Therapeutics Highlights Pipeline Progress and Upcoming Milestones and Reports Third Quarter 2022 Financial Results
Oct 17, 2022
MarketScreener
Design Therapeutics: Design Therapeutics to Present Preclinical Data Highlighting the Potential of its GeneTAC Small Molecule, DT-216, for the Treatment of Friedreich Ataxia at ICAR 2022
Design Therapeutics Competitors
1
2
3
4
5
6
7
8
9
10
Looking for similar companies to Design Therapeutics?
Design Therapeutics News
Design Therapeutics Press Releases
Design Therapeutics Headquarters
Design Therapeutics Summary
ABOUT
Overview
Design Therapeutics is a biotechnology company that develops and commercializes therapies for the treatment of degenerative diseases. Design Therapeutics was founded in 2017. Design Therapeutics' headquarters is located in Carlsbad, California, USA 92...CEO
Design Therapeutics's President & CEO, Joao Siffert, currently has an approval rating of 90%. Design Therapeutics's primary competitors are CRISPR, Beam, Retrotope and 15 more.Website
designtx.comAcquisitions
There have been no acquisitions found related to Design TherapeuticsInvestments
Recent investment data cannot be found related to Design TherapeuticsFrequently Asked Questions about Design Therapeutics
When was Design Therapeutics founded?
Design Therapeutics was founded in 2017Who is Design Therapeutics's CEO?
Design Therapeutics's CEO is Joao SiffertHow much revenue does Design Therapeutics generate?
Design Therapeutics generates $ < 1M in revenueHow much funding does Design Therapeutics have?
Design Therapeutics has historically raised $410.5M in funding
Where is Design Therapeutics's headquarters?
Design Therapeutics's headquarters is in Carlsbad California, USAHow many employees does Design Therapeutics have?
Design Therapeutics has 40 employeesWhat sector does Design Therapeutics operate in?
Design Therapeutics is in Biotechnology, PharmaceuticalsWho are Design Therapeutics's competitors?
Design Therapeutics's top competitors are CRISPR, Beam, Retrotope